Lisa Peraza
Net worth: 107 550 $ as of 29/06/2026
Net worth: 107 550 $ as of 29/06/2026
Lisa Peraza is Vice President-Finance at Connect Biopharma Holdings Ltd. since 2024.
Formerly, Ms. Peraza was Chief Accounting Officer & Vice President at Heron Therapeutics, Inc. from 2020 to 2024 and Executive Director & Controller at Ardea Biosciences, Inc. from 2008 to 2014.
Education includes undergraduate studies at the University of California, Santa Barbara.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/03/2026 | 45,189 ( 0.08% ) | 107 550 $ | 29/06/2026 |
| Companies | Position | Start |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Director of Finance/CFO | 12/09/2024 |
| Companies | Position | End |
|---|---|---|
| HERON THERAPEUTICS, INC. | Chief Administrative Officer | - |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Director/Board Member | 28/02/2014 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Connect Biopharma Holdings Ltd.
Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions